181 related articles for article (PubMed ID: 30777927)
1. Association between peroxisome proliferator-activated receptor γ-2 gene Pro12Ala polymorphisms and risk of hypertension: an updated meta-analysis.
Zhang M; Zhang J; Li L; Wang Q; Feng L
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30777927
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of PPAR-γ2 Pro12Ala polymorphism with hypertension.
Yang W; Wang J; Ye W; Li X
Herz; 2018 Dec; 43(8):719-727. PubMed ID: 28920998
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
[TBL] [Abstract][Full Text] [Related]
4. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.
Wei Z; Han G; Bai X
Med Sci Monit; 2015 Jun; 21():1611-6. PubMed ID: 26049557
[TBL] [Abstract][Full Text] [Related]
5. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis.
Xie R; Tang S; Yang Y
J Diabetes Complications; 2022 Oct; 36(10):108261. PubMed ID: 36055011
[TBL] [Abstract][Full Text] [Related]
6. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.
Radha V; Vimaleswaran KS; Babu HN; Abate N; Chandalia M; Satija P; Grundy SM; Ghosh S; Majumder PP; Deepa R; Rao SM; Mohan V
Diabetes Care; 2006 May; 29(5):1046-51. PubMed ID: 16644635
[TBL] [Abstract][Full Text] [Related]
7. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.
Zhao J; Zhi Z; Song G; Wang J; Wang C; Ma H; Yu X; Sui A; Zhang H
Asian Pac J Cancer Prev; 2015; 16(6):2333-40. PubMed ID: 25824760
[TBL] [Abstract][Full Text] [Related]
9. The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPARγ2) is associated with increased risk of coronary artery disease: a meta-analysis.
Wu Z; Lou Y; Jin W; Liu Y; Lu L; Lu G
PLoS One; 2012; 7(12):e53105. PubMed ID: 23300871
[TBL] [Abstract][Full Text] [Related]
10. The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.
Wang L; Teng Z; Cai S; Wang D; Zhao X; Yu K
Diagn Pathol; 2013 Jul; 8():118. PubMed ID: 23856170
[TBL] [Abstract][Full Text] [Related]
11. Associations between PPARG polymorphisms and the risk of essential hypertension.
Cai G; Zhang X; Weng W; Shi G; Xue S; Zhang B
PLoS One; 2017; 12(7):e0181644. PubMed ID: 28727849
[TBL] [Abstract][Full Text] [Related]
12. Association between Peroxisome Proliferator-activated Receptor Gamma Gene Polymorphisms and Atherosclerotic Diseases: A Meta-analysis of Case-control Studies.
Wang P; Wang Q; Yin Y; Yang Z; Li W; Liang D; Zhou P
J Atheroscler Thromb; 2015; 22(9):912-25. PubMed ID: 25832497
[TBL] [Abstract][Full Text] [Related]
13. COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.
Lee YH; Song GG
Neurol Sci; 2014 May; 35(5):643-51. PubMed ID: 24477323
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of common polymorphism (rs1801282) in the PPARγ2 gene and hypertension susceptibility.
Wang Y; Liu C
Gene; 2012 Jul; 502(2):159-62. PubMed ID: 22561695
[TBL] [Abstract][Full Text] [Related]
15. Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis.
Yao YS; Li J; Jin YL; Chen Y; He LP
Mol Biol Rep; 2015 Jun; 42(6):1029-38. PubMed ID: 25502405
[TBL] [Abstract][Full Text] [Related]
16. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
[TBL] [Abstract][Full Text] [Related]
17. PPARG Pro12Ala Polymorphism with CKD in Asians: A Meta-Analysis Combined with a Case-Control Study-A Key for Reaching Null Association.
Chen HC; Chen WT; Sung TL; Tsai DJ; Lin C; Su H; Lin YF; Chiu HY; Su SL
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32604723
[TBL] [Abstract][Full Text] [Related]
18. Association of peroxisome proliferator-activated receptor γ polymorphisms and haplotypes with essential hypertension.
Gu SJ; Guo ZR; Wu M; Ding Y; Luo WS
Genet Test Mol Biomarkers; 2013 May; 17(5):418-23. PubMed ID: 23530462
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis of the association between PPARγ2 gene Pro12Ala polymorphism and obesity in Chinese population].
Li M; Wang Y; Ayiguli A; Haiqiemuhan A; Liu Z
Wei Sheng Yan Jiu; 2021 Mar; 50(2):315-319. PubMed ID: 33985643
[TBL] [Abstract][Full Text] [Related]
20. Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.
Zhou TB; Guo XF; Yin SS
J Recept Signal Transduct Res; 2014 Jun; 34(3):180-4. PubMed ID: 24329532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
